<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06010000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P08631</UniProt_ID>
  <Seq_Length>526</Seq_Length>
  <Molecule_Weight>59600</Molecule_Weight>
  <KEGG_ID>hsa:3055</KEGG_ID>
  <Orthology_ID>K08893</Orthology_ID>
  <EBI_ID>EBI-346340</EBI_ID>
  <Function_Summary>Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS.</Function_Summary>
  <Catalytic_Mechanism>ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF07714:Pkinase_Tyr@@PF00017:SH2@@PF00018:SH3_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>p59-HCK/p60-HCK</Alias>
      <Alias>p61Hck</Alias>
      <Alias>Hematopoietic cell kinase</Alias>
      <Alias>p59Hck</Alias>
      <Alias>Hemopoietic cell kinase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.</Detail>
      <Keyword>Protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004713</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a non-membrane spanning protein L-tyrosine = ADP + a non-membrane spanning protein L-tyrosine phosphate.</Detail>
      <Keyword>Non-membrane spanning protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004715</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>105</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>502</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>399</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.</Detail>
      <Keyword>Regulation of defense response to virus by virus</Keyword>
      <Ontology_ID>GO:0050690</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to activation or perpetuation of an innate immune response.</Detail>
      <Keyword>Innate immune response-activating signal transduction</Keyword>
      <Ontology_ID>GO:0002758</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle by fusion of the vesicle with the plasma membrane of a cell. This is the process in which most molecules are secreted from eukaryotic cells.</Detail>
      <Keyword>Exocytosis</Keyword>
      <Ontology_ID>GO:0006887</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of cell proliferation.</Detail>
      <Keyword>Positive regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008284</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material.</Detail>
      <Keyword>Regulation of phagocytosis</Keyword>
      <Ontology_ID>GO:0050764</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a leukocyte within or between different tissues and organs of the body as part of an immune response.</Detail>
      <Keyword>Leukocyte migration involved in immune response</Keyword>
      <Ontology_ID>GO:0002522</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.</Detail>
      <Keyword>Regulation of transcription factor activity</Keyword>
      <Ontology_ID>GO:0051090</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules by a leukocyte.</Detail>
      <Keyword>Leukocyte degranulation</Keyword>
      <Ontology_ID>GO:0043299</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of an integrin binding to one of its physiological ligands.</Detail>
      <Keyword>Integrin-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0007229</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Negative regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.</Detail>
      <Keyword>Mesoderm development</Keyword>
      <Ontology_ID>GO:0007498</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a virus reproduces. Usually, this is by infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.</Detail>
      <Keyword>Viral reproduction</Keyword>
      <Ontology_ID>GO:0016032</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.</Detail>
      <Keyword>Phagocytosis</Keyword>
      <Ontology_ID>GO:0006909</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of podosome assembly.</Detail>
      <Keyword>Regulation of podosome assembly</Keyword>
      <Ontology_ID>GO:0071801</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The phosphorylation by a protein of one or more of its own amino acid residues, or residues on an identical protein.</Detail>
      <Keyword>Protein autophosphorylation</Keyword>
      <Ontology_ID>GO:0046777</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of actin polymerization.</Detail>
      <Keyword>Positive regulation of actin filament polymerization</Keyword>
      <Ontology_ID>GO:0030838</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the surface configuration of a cell.</Detail>
      <Keyword>Regulation of cell shape</Keyword>
      <Ontology_ID>GO:0008360</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.</Detail>
      <Keyword>Regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050727</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization.</Detail>
      <Keyword>Positive regulation of actin cytoskeleton reorganization</Keyword>
      <Ontology_ID>GO:2000251</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.</Detail>
      <Keyword>Interferon-gamma-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0060333</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated in response to detection of lipopolysaccharide. Lipopolysaccharides (LPS) are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.</Detail>
      <Keyword>Lipopolysaccharide-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0031663</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.</Detail>
      <Keyword>Peptidyl-tyrosine phosphorylation</Keyword>
      <Ontology_ID>GO:0018108</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A phase of elevated metabolic activity, during which oxygen consumption increases, that occurs in neutrophils, monocytes, and macrophages shortly after phagocytosing material. An enhanced uptake of oxygen leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals, which play a part in microbiocidal activity.</Detail>
      <Keyword>Respiratory burst after phagocytosis</Keyword>
      <Ontology_ID>GO:0045728</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>462</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>411</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>202</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>515</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>36</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>522</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>330</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>209</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>127</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>520</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>51</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGGRSSCEDPGCPRDEERAPRMGCMKSKFLQVGGNTFSKTETSASPHCPVYVPDPTSTIKPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP</Protein_Seq>
    <DNA_Seq>GGAGTTAGCCTCGCTCAGGGCGCGGCTAAGGCGCCCAGATGGCCTGCGGGCGCCACCACGTCCCTGGTCCCAGCTCGGGAGCACATCAGAGGCTTAGAGGCGAGTGGGAAGGGACTCAGACAGTGCAGGACGAGAAACGCCCGCGGCACCAAAGCCCCTCAGAGCGTCGCCCCCGCCTCTAGTTCTAGAAAGTCAGTTTCCCGGCACTGGCACCCCGGAACCTCAGGGGCTGCCGAGCTGGGGGGGCGCTCAAGCTGCGAGGATCCGGGCTGCCCGCGAGACGAGGAGCGGGCGCCCAGGATGGGGTGCATGAAGTCCAAGTTCCTCCAGGTCGGAGGCAATACATTCTCAAAAACTGAAACCAGCGCCAGCCCACACTGTCCTGTGTACGTGCCGGATCCCACATCCACCATCAAGCCGGGGCCTAATAGCCACAACAGCAACACACCAGGAATCAGGGAGGCAGGCTCTGAGGACATCATCGTGGTTGCCCTGTATGATTACGAGGCCATTCACCACGAAGACCTCAGCTTCCAGAAGGGGGACCAGATGGTGGTCCTAGAGGAATCCGGGGAGTGGTGGAAGGCTCGATCCCTGGCCACCCGGAAGGAGGGCTACATCCCAAGCAACTATGTCGCCCGCGTTGACTCTCTGGAGACAGAGGAGTGGTTTTTCAAGGGCATCAGCCGGAAGGACGCAGAGCGCCAACTGCTGGCTCCCGGCAACATGCTGGGCTCCTTCATGATCCGGGATAGCGAGACCACTAAAGGAAGCTACTCTTTGTCCGTGCGAGACTACGACCCTCGGCAGGGAGATACCGTGAAACATTACAAGATCCGGACCCTGGACAACGGGGGCTTCTACATATCCCCCCGAAGCACCTTCAGCACTCTGCAGGAGCTGGTGGACCACTACAAGAAGGGGAACGACGGGCTCTGCCAGAAACTGTCGGTGCCCTGCATGTCTTCCAAGCCCCAGAAGCCTTGGGAGAAAGATGCCTGGGAGATCCCTCGGGAATCCCTCAAGCTGGAGAAGAAACTTGGAGCTGGGCAGTTTGGGGAAGTCTGGATGGCCACCTACAACAAGCACACCAAGGTGGCAGTGAAGACGATGAAGCCAGGGAGCATGTCGGTGGAGGCCTTCCTGGCAGAGGCCAACGTGATGAAAACTCTGCAGCATGACAAGCTGGTCAAACTTCATGCGGTGGTCACCAAGGAGCCCATCTACATCATCACGGAGTTCATGGCCAAAGGAAGCTTGCTGGACTTTCTGAAAAGTGATGAGGGCAGCAAGCAGCCATTGCCAAAACTCATTGACTTCTCAGCCCAGATTGCAGAAGGCATGGCCTTCATCGAGCAGAGGAACTACATCCACCGAGACCTCCGAGCTGCCAACATCTTGGTCTCTGCATCCCTGGTGTGTAAGATTGCTGACTTTGGCCTGGCCCGGGTCATTGAGGACAACGAGTACACGGCTCGGGAAGGGGCCAAGTTCCCCATCAAGTGGACAGCTCCTGAAGCCATCAACTTTGGCTCCTTCACCATCAAGTCAGACGTCTGGTCCTTTGGTATCCTGCTGATGGAGATCGTCACCTACGGCCGGATCCCTTACCCAGGGATGTCAAACCCTGAAGTGATCCGAGCTCTGGAGCGTGGATACCGGATGCCTCGCCCAGAGAACTGCCCAGAGGAGCTCTACAACATCATGATGCGCTGCTGGAAAAACCGTCCGGAGGAGCGGCCGACCTTCGAATACATCCAGAGTGTGCTGGATGACTTCTACACGGCCACAGAGAGCCAGTACCAACAGCAGCCATGATAGGGAGGACCAGGGCAGGGCCAGGGGGTGCCCAGGTGGTGGCTGCAAGGTGGCTCCAGCACCATCCGCCAGGGCCCACACCCCCTTCCTACTCCCAGACACCCACCCTCGCTTCAGCCACAGTTTCCTCATCTGTCCAGTGGGTAGGTTGGACTGGAAAATCTCTTTTTGACTCTTGCAATCCACAATCTGACATTCTCAGGAAGCCCCCAAGTTGATATTTCTATTTCCTGGAATGGTTGGATTTTAGTTACAGCTGTGATTTGGAAGGGAAACTTTCAAAATAGTGAAATGAATATTTAAATAAAAGATATAAATGCCAAAGTCTTTACCAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>B-lymphoid lineages</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Tonsil</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Neutrophils</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Granulocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Monocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Cells of the myeloid</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell junction</CellLocal>
      <Ontology_ID>GO:0030054</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Lysosome</CellLocal>
      <Ontology_ID>GO:0005764</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
      <Ontology_ID>GO:0005856</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extrinsic to internal side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0031234</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi apparatus</CellLocal>
      <Ontology_ID>GO:0005794</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Caveola</CellLocal>
      <Ontology_ID>GO:0005901</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic vesicle</CellLocal>
      <Ontology_ID>GO:0031410</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Focal adhesion</CellLocal>
      <Ontology_ID>GO:0005925</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell projection</CellLocal>
      <Ontology_ID>GO:0042995</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Transport vesicle</CellLocal>
      <Ontology_ID>GO:0030133</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HCK</Gene_Name>
    <Gene_ID>3055</Gene_ID>
    <Genbank_ACCN>NM_001172129</Genbank_ACCN>
    <Protein_ACCN>NP_001165600</Protein_ACCN>
    <HGNC_ID>4840</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3055</Gene_URL>
    <UCSC_ID>uc002wxh.3</UCSC_ID>
    <EMBL_ID>ENSG00000101336</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P12504</Uniprot_ID>
      <Gene_Name>vif</Gene_Name>
      <EBI_ID>EBI-779991</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-779991</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O43516</Uniprot_ID>
      <Gene_Name>WIPF1</Gene_Name>
      <EBI_ID>EBI-346356</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-346356</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P08631</Uniprot_ID>
      <Gene_Name>HCK</Gene_Name>
      <EBI_ID>EBI-706378</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-706378</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07666</Uniprot_ID>
      <Gene_Name>KHDRBS1</Gene_Name>
      <EBI_ID>EBI-1364</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-1364</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P08631</Uniprot_ID>
      <Gene_Name>HCK</Gene_Name>
      <EBI_ID>EBI-710506</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-710506</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92556</Uniprot_ID>
      <Gene_Name>ELMO1</Gene_Name>
      <EBI_ID>EBI-346417</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-346417</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P42768</Uniprot_ID>
      <Gene_Name>WAS</Gene_Name>
      <EBI_ID>EBI-346375</EBI_ID>
      <PPI_EBI_URL>EBI-346340,EBI-346375</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Cervical Adenosquamous Carcinoma</Disease_Name>
      <Disease_Detail>Cervical Cancer</Disease_Detail>
      <Disease_DB>CRV033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cervical_adenosquamous_carcinoma?search=HCK#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenosquamous Carcinoma</Disease_Name>
      <Disease_Detail>Adenosquamous Carcinoma</Disease_Detail>
      <Disease_DB>ADN009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenosquamous_carcinoma?search=HCK#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041</PDB_Title>
      <PDB_ID>2C0O</PDB_ID>
      <Resolution>2.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C0O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection.</PubMed_Title>
      <Author>Burchat, A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:118</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16216497?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK SH3 DOMAIN</PDB_Title>
      <PDB_ID>1BU1</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BU1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.</PubMed_Title>
      <Author>Arold, S., et al.</Author>
      <Journal>Biochemistry(1998)37:14683-14691</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9778343?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN HCK SH3 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>5HCK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=5HCK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the human Hck SH3 domain and identification of its ligand binding site.</PubMed_Title>
      <Author>Horita, D.A., et al.</Author>
      <Journal>J.Mol.Biol.(1998)278:253-265</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9571048?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high affinity ligand (PD1)</PDB_Title>
      <PDB_ID>2OI3</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OI3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of a Hck SH3 Domain Ligand  Complex Reveals Novel Interaction Modes</PubMed_Title>
      <Author>Schmidt, H., et al.</Author>
      <Journal>J.Mol.Biol.(2007)365:1517-1532</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17141806?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Nef protein in complex with engineered Hck-SH3 domain</PDB_Title>
      <PDB_ID>3REB</PDB_ID>
      <Resolution>3.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3REB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Design, Functional Characterization and Structural Basis of a Protein Inhibitor Against the HIV-1 Pathogenicity Factor Nef</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the SRC-family kinase HCK SH3-SH2-linker regulatory region</PDB_Title>
      <PDB_ID>3NHN</PDB_ID>
      <Resolution>2.61</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NHN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Src Family Kinase Hck SH3-SH2 Linker Regulatory Region Supports an SH3-dominant Activation Mechanism.</PubMed_Title>
      <Author>Alvarado, J.J., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:35455-35461</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20810664?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 NEF protein in complex with engineered HCK SH3 domain</PDB_Title>
      <PDB_ID>3RBB</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RBB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conformation of the Dileucine-Based Sorting Motif in HIV-1 Nef Revealed by Intermolecular Domain Assembly.</PubMed_Title>
      <Author>Horenkamp, F.A., et al.</Author>
      <Journal>Traffic(2011)12:867-877</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21477083?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR ensemble of the uncomplexed human HCK SH2 domain, 20 structures</PDB_Title>
      <PDB_ID>3HCK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HCK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Sequential assignment and secondary structure determination for the Src homology 2 domain of hematopoietic cellular kinase.</PubMed_Title>
      <Author>Zhang, W., et al.</Author>
      <Journal>FEBS Lett.(1997)406:131-135</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9109402?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK-QUERCETIN COMPLEX</PDB_Title>
      <PDB_ID>2HCK</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HCK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the Src family tyrosine kinase Hck.</PubMed_Title>
      <Author>Sicheri, F., et al.</Author>
      <Journal>Nature(1997)385:602-609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9024658?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURES</PDB_Title>
      <PDB_ID>4HCK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4HCK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the human Hck SH3 domain and identification of its ligand binding site.</PubMed_Title>
      <Author>Horita, D.A., et al.</Author>
      <Journal>J.Mol.Biol.(1998)278:253-265</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9571048?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359</PDB_Title>
      <PDB_ID>2C0T</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C0T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection.</PubMed_Title>
      <Author>Burchat, A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:118</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16216497?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK-AMP-PNP COMPLEX</PDB_Title>
      <PDB_ID>1AD5</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AD5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the Src family tyrosine kinase Hck.</PubMed_Title>
      <Author>Sicheri, F., et al.</Author>
      <Journal>Nature(1997)385:602-609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9024658?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high affinity ligand (PD1)</PDB_Title>
      <PDB_ID>2OJ2</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OJ2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of a Hck SH3 Domain Ligand Complex Reveals Novel Interaction Modes</PubMed_Title>
      <Author>Schmidt, H., et al.</Author>
      <Journal>J.Mol.Biol.(2007)365:1517-1532</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17141806?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247</PDB_Title>
      <PDB_ID>2HK5</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HK5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).</PubMed_Title>
      <Author>Sabat, M., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:5973-5977</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16997556?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Nef protein in complex with engineered Hck-SH3 domain</PDB_Title>
      <PDB_ID>3REA</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3REA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Design, Functional Characterization and Structural Basis of a Protein Inhibitor Against the HIV-1 Pathogenicity Factor Nef</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR</PDB_Title>
      <PDB_ID>1QCF</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.</PubMed_Title>
      <Author>Schindler, T., et al.</Author>
      <Journal>Mol.Cell(1999)3:639-648</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10360180?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983</PDB_Title>
      <PDB_ID>2C0I</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C0I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection.</PubMed_Title>
      <Author>Burchat, A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:118</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16216497?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.gc.c.b.ba.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1bu1</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Allosteric switch</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.10.2</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/10/2.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>